Literature DB >> 12966792

[Therapy of tropical diseases after returning from travel].

G D Burchard1, H Sudeck.   

Abstract

Most tropical diseases imported by travelers can be treated quite effectively. Human endoparasites belong to the protozoa and worms. Protozoa can be seen as microparasites, characterized by short generation periods and high rates of reproduction within a host--consequently the diseases mainly are of short duration. Effective drugs are available for malaria, amebiasis and other intestinal protozoa as well as for leishmaniasis. Resistance, however, sometimes is a problem. Worms are macroparasites that generally do not reproduce within a host--teleologically speaking because otherwise they would rapidly damage their own basis of living. Accordingly, severe worm disease is rarely found in travelers. Levels of anthelminthic resistances so far are low. The most important worm disease in travelers is schistosomiasis, a disease that also can be treated effectively if diagnosed early.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966792     DOI: 10.1007/s00108-003-0882-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  80 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis.

Authors:  Mark S Riddle; Jeffrey L Jackson; John W Sanders; David L Blazes
Journal:  Clin Infect Dis       Date:  2002-04-03       Impact factor: 9.079

3.  Uncomplicated amebic liver abscess: prospective evaluation of percutaneous therapeutic aspiration.

Authors:  R J Van Allan; M D Katz; M B Johnson; L A Laine; Y Liu; P W Ralls
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

4.  Double-blind therapeutical evaluation based on the quantitative oogram technique, comparing praziquantel and oxamniquine in human schistosomiasis mansoni.

Authors:  A S da Cunha; R C Pedrosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1986 Sep-Oct       Impact factor: 1.846

5.  A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.

Authors:  G Lefèvre; S Looareesuwan; S Treeprasertsuk; S Krudsood; U Silachamroon; I Gathmann; R Mull; R Bakshi
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

6.  Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.

Authors:  G Krause; A Kroeger
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jan-Feb       Impact factor: 2.184

Review 7.  Interventions for treating schistosomiasis mansoni.

Authors:  H Saconato; A Atallah
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 8.  Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.

Authors:  S Looareesuwan; J D Chulay; C J Canfield; D B Hutchinson
Journal:  Am J Trop Med Hyg       Date:  1999-04       Impact factor: 2.345

9.  Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.

Authors:  S Sundar; T K Jha; C P Thakur; M Mishra; V R Singh; R Buffels
Journal:  Am J Trop Med Hyg       Date:  2002-02       Impact factor: 2.345

10.  Acute renal failure in patients with severe falciparum malaria.

Authors:  T T Trang; N H Phu; H Vinh; T T Hien; B M Cuong; T T Chau; N T Mai; D J Waller; N J White
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.